Close Menu

Just Getting By

At Genetic Future, Daniel MacArthur points out a press release from Decode Genetics on their second quarter financials. According to the release, the company brought in $3.5 million for 2009 as compared to $9.0 million for the same quarter last year. "The goal of our strategic review is to recast deCODE as a diagnostics company positioned to lead in this growing new market," CEO Kari Stefansson says in the statement.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A UK study on mixing SARS-CoV-2 vaccines is expanding to include vaccines developed by additional companies, according to the Guardian.

According to Science, the US National Academy of Sciences is poised to eject two members accused of sexual harassment.

In Nucleic Acids Research this week: machine learning approach to detect DNA-bound proteins, CRISPR-based method for activating specific gene targets, and more.

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.